Abstract
Revolutionary plant-derived enzyme technology prevents chalcone cyclization, enabling stable biosynthesis of valuable bioactive polyphenols for pharmaceutical, nutraceutical and food applications.
Background
Chalcones represent a $2 billion global market segment within the broader polyphenols industry, projected to reach $3 billion by 2028[1]. These valuable natural compounds demonstrate potent antioxidant, anti-inflammatory, antimicrobial, and anticancer properties, making them highly sought after in cosmetics, nutraceuticals, and pharmaceutical research. The global antioxidant market alone is expected to reach $5 billion by 2025[2].
However, chalcone production faces a critical bottleneck: inherent chemical instability. In biological systems, chalcones spontaneously cyclize into flavanones, severely limiting their utility as end-products and creating significant manufacturing challenges. Current synthetic production methods are costly, environmentally harsh, and often produce unstable products with limited shelf life.
Key Competitors:
- Chemical synthesis companies (DSM, BASF) offering expensive synthetic chalcones
- Extraction-based companies producing unstable natural chalcones with short shelf life
- Biotechnology firms attempting microbial production with low yields due to instability
[1] https://www.grandviewresearch.com/industry-analysis/polyphenols-market-analysis
[2] https://www.fortunebusinessinsights.com/industry-reports/food-antioxidants-market-100789
Our Innovation
We have discovered a novel plant-derived enzyme that effectively stabilizes chalcones by preventing their conversion to flavanones, maintaining them in their bioactive open-chain form.
Major Technological Advantages:
- Enhanced Stability: Prevents spontaneous cyclization, extending product shelf life
- Superior Biosynthesis Efficiency: Enables consistent microbial or plant-based production with higher yields than current methods
- Broad Substrate Specificity: . Demonstrates versatility across multiple high-value compounds
- Cost-Effective Production: Biological production system reduces manufacturing costs compared to chemical synthesis
- Regulatory Advantage: Natural enzyme origin provides cleaner regulatory pathway for food and pharmaceutical applications
Technology
Our proprietary enzyme acts prevents the reaction that converts chalcones to flavanones. The enzyme demonstrates robust activity across multiple chalcone substrates, suggesting broad applicability for industrial biosynthesis. This breakthrough enables:
- Consistent production in engineered microbial systems (E. coli, yeast)
- Enhanced yields in plant-based production systems
- Extended product stability for commercial applications
- Facilitated downstream processing and purification
The technology can be integrated into existing biotechnology production platforms, making it highly scalable and commercially viable.
Opportunity
The researchers are seeking an industry partner to collaborate and sponsor additional research and development. The partner will receive an option to license the intellectual property at the conclusion of the R&D collaboration. This represents a unique opportunity to enter the rapidly growing polyphenols market with a disruptive technology that addresses the industry’s primary production challenge.
Patents & Publications
Patent application in preparation for novel chalcone-stabilizing enzyme and its applications in biotechnology production systems.
